Trial NCT03704298

View at ClinicalTrials.gov 
Org. Study IDs: KTE-C19-111

Last trial update was posted on 2022-12-22

MeSH Interventions

Axicabtagene ciloleucel Cyclophosphamide Fludarabine

MeSH Conditions

Lymphoma Lymphoma, B-Cell

Other Conditions

Relapsed/Refractory Large B-cell Lymphoma

Stopping Reasons

Development program terminated

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID